IQI
RPRX icon

Integrated Quantitative Investments’s Royalty Pharma RPRX Stock Holding History

Integrated Quantitative Investments’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,192
Closed -$489K – 506
2026
Q1 		$489K Buy
10,192
+3,665
+56% +$161K 0.09% 272
2025
Q4 		$252K Hold
6,527
– – 0.05% 358
2025
Q3 		$230K Sell
6,527
-5,300
-45% -$192K 0.07% 314
2025
Q2 		$426K Buy
11,827
+1,627
+16% +$53.9K 0.13% 235
2025
Q1 		$318K Sell
10,200
-5,100
-33% -$162K 0.16% 189
2024
Q4 		$390K Buy
+15,300
New +$406K 0.19% 153

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Integrated Quantitative Investments's RPRX Position: Q2 2026 in Review

Integrated Quantitative Investments sold out of Royalty Pharma (RPRX) in Q2 2026, closing a stake of 10,192 shares — an estimated $489K sold.

Integrated Quantitative Investments first reported a position in RPRX in Q4 2024 and held it in 6 quarters. The position peaked at $489K in Q1 2026. 645 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Integrated Quantitative Investments reported no remaining Royalty Pharma position as of Q2 2026 after selling out during the quarter.
  • Integrated Quantitative Investments sold 10,192 Royalty Pharma shares in Q2 2026, an estimated $489K.
  • Integrated Quantitative Investments first reported a position in Royalty Pharma in Q4 2024 and held it in 6 quarters.
  • Integrated Quantitative Investments's Royalty Pharma position peaked at $489K in Q1 2026.
  • 645 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Integrated Quantitative Investments's 13F filing for Q2 2026, filed 14 Aug 2026.